A
Antonia Zapantis
Researcher at Nova Southeastern University
Publications - 17
Citations - 382
Antonia Zapantis is an academic researcher from Nova Southeastern University. The author has contributed to research in topics: Pharmacy practice & Pharmacy. The author has an hindex of 10, co-authored 17 publications receiving 352 citations.
Papers
More filters
Journal ArticleDOI
Nationwide antibiogram analysis using NCCLS M39-A guidelines.
Antonia Zapantis,Melinda K. Lacy,Rebecca T. Horvat,Dennis Grauer,Brian J. Barnes,Brian C. O’Neal,Rick Couldry +6 more
TL;DR: It is suggested that antibiograms should be reviewed thoroughly by infectious disease specialists, clinical microbiologists, and infection control personnel for identification of abnormal findings prior to distribution.
Journal ArticleDOI
Use of Herbals as Galactagogues
TL;DR: Despite the fact that postpartum women may turn to herbal galactagogues, scant clinical evidence exists to justify their effectiveness and further clinical trials are needed in order to substantiate these findings.
Journal ArticleDOI
Ability of online drug databases to assist in clinical decision-making with infectious disease therapies
TL;DR: Drug information databases used in ID practice as CDSTs were shown to be superior in their scope and completeness of information, and MM, AHFS, and MDR provided no erroneous answers.
Journal ArticleDOI
Current Practices in Global/International Advanced Pharmacy Practice Experiences: Preceptor and Student Considerations.
Emily K. Dornblaser,Anna Ratka,Shaun E. Gleason,David Ombengi,Toyin Tofade,Patricia R. Wigle,Antonia Zapantis,Melody Ryan,Sharon E. Connor,Lauren J. Jonkman,Leslie Ochs,Paul W. Jungnickel,Jeanine P. Abrons,Naser Z. Alsharif +13 more
TL;DR: Considerations related to preceptors and students and learning outcomes are described and recommendations and future directions for development of G/IAPPEs are presented.
Journal ArticleDOI
Antibiograms: New NCCLS guidelines, development, and clinical application
TL;DR: Common antimicrobial susceptibility testing methods and relevant issues are reviewed, the major NCCLS M39-A recommendations are highlighted, the antibiogram preparation process and challenges in data interpretation are discussed, and a general overview of how antibiograms data may be applied to clinical practice is provided.